Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
258.94
+0.16 (0.06%)
Dec 19, 2024, 10:54 AM EST - Market open
Amgen Employees
Amgen had 26,700 employees as of December 31, 2023. The number of employees increased by 1,500 or 5.95% compared to the previous year.
Employees
26,700
Change (1Y)
1,500
Growth (1Y)
5.95%
Revenue / Employee
$1,218,502
Profits / Employee
$158,427
Market Cap
138.52B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 26,700 | 1,500 | 5.95% |
Dec 31, 2022 | 25,200 | 1,000 | 4.13% |
Dec 31, 2021 | 24,200 | -100 | -0.41% |
Dec 31, 2020 | 24,300 | 900 | 3.85% |
Dec 31, 2019 | 23,400 | 1,900 | 8.84% |
Dec 31, 2018 | 21,500 | 700 | 3.37% |
Dec 31, 2017 | 20,800 | 1,600 | 8.33% |
Dec 31, 2016 | 19,200 | 1,300 | 7.26% |
Dec 31, 2015 | 17,900 | 0 | - |
Dec 31, 2014 | 17,900 | -2,100 | -10.50% |
Dec 31, 2013 | 20,000 | 2,000 | 11.11% |
Dec 31, 2012 | 18,000 | 200 | 1.12% |
Dec 31, 2011 | 17,800 | 400 | 2.30% |
Dec 31, 2010 | 17,400 | 200 | 1.16% |
Dec 31, 2009 | 17,200 | 300 | 1.78% |
Dec 31, 2008 | 16,900 | -600 | -3.43% |
Dec 31, 2007 | 17,500 | -2,600 | -12.94% |
Dec 31, 2006 | 20,100 | 3,600 | 21.82% |
Dec 31, 2005 | 16,500 | 2,100 | 14.58% |
Dec 31, 2004 | 14,400 | 1,500 | 11.63% |
Dec 31, 2003 | 12,900 | 2,800 | 27.72% |
Dec 31, 2002 | 10,100 | 2,400 | 31.17% |
Dec 31, 2001 | 7,700 | 400 | 5.48% |
Dec 31, 2000 | 7,300 | 900 | 14.06% |
Dec 31, 1999 | 6,400 | 900 | 16.36% |
Dec 31, 1998 | 5,500 | 192 | 3.62% |
Dec 31, 1997 | 5,308 | 662 | 14.25% |
Dec 31, 1996 | 4,646 | 600 | 14.83% |
Dec 31, 1995 | 4,046 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Abbott Laboratories | 114,000 |
Pfizer | 88,000 |
Sanofi | 86,088 |
Novartis AG | 76,057 |
Danaher | 63,000 |
Boston Scientific | 48,000 |
Bristol-Myers Squibb Company | 34,100 |
Stryker | 26,700 |
AMGN News
- 2 days ago - PESG Releases Market Update: Silexion Therapeutics Advances KRAS-Targeting Therapies with New Collaboration As Industry Demand for Precision Oncology Solutions Rises - Business Wire
- 5 days ago - Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value - Seeking Alpha
- 8 days ago - AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND - PRNewsWire
- 12 days ago - BLINCYTO® (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN NEWLY DIAGNOSED PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) - PRNewsWire
- 14 days ago - Healthy Returns: Wall Street mulls over Amgen's weight loss drug data - CNBC
- 14 days ago - Amgen to invest $1 bln in North Carolina manufacturing site - Reuters
- 14 days ago - AMGEN ANNOUNCES $1 BILLION MANUFACTURING EXPANSION IN NORTH CAROLINA - PRNewsWire
- 14 days ago - Dow 30 December Dogs Show 28 Pay Dividends And 1 "Safer" Buy - Seeking Alpha